PRECLINICAL EVALUATION OF A NEW POTENT IMMUNOSUPPRESSIVE AGENT, RAPAMYCIN
PRESIDENTIAL ADDRESS, 1990, TO THE AMERICAN SOCIETY OF TRANSPLANT PHYSICIANS
CHRONIC RENAL ALLOGRAFT REJECTION
TOXICITY OF RAPAMYCIN—A COMPARATIVE AND COMBINATION STUDY WITH CYCLOSPORINE AT IMMUNOTHERAPEUTIC DOSAGE IN THE RAT
AUTOMATED LARGE-SCALE ISOLATION, IN VITRO FUNCTION AND XENOTRANSPLANTATION OF PORCINE ISLETS OF LANGERHANS
IMMUNOPATHOLOGY OF HYPERACUTE XENOGRAFT REJECTION IN A SWINE-TO-PRIMATE MODEL
INTESTINAL PERMEABILITY AND BACTERIAL TRANSLOCATION FOLLOWING SMALL BOWEL TRANSPLANTATION IN THE RAT
INCREASE IN SURVIVAL OF LIVER GRAFTS AFTER RINSING WITH WARM RINGER'S SOLUTION DUE TO IMPROVEMENT OF HEPATIC MICROCIRCULATION
SIXTY-MINUTE NORMOTHERMIC LIVER ISCHEMIA IN RATS
EVIDENCE THAT LS-2616 (LINOMIDE) CAUSES ACUTE REJECTION OF RAT ALLOGRAFTS PROTECTED BY CYCLOSPORINE BUT NOT OF LONG-TERM SURVIVING ALLOGRAFTS
PROGRESSION OF KIDNEY DISEASE IN CHRONIC RENAL TRANSPLANT REJECTION
RISK FACTOR ANALYSIS FOR THE MAJOR HAZARDS FOLLOWING HEART TRANSPLANTATION—REJECTION, INFECTION, AND CORONARY OCCLUSIVE DISEASE
RISK FACTORS FOR SECOND RENAL ALLOGRAFTS IMMUNOSUPPRESSED WITH CYCLOSPORINE
WHICH RENAL TRANSPLANT PATIENTS SHOULD RECEIVE CYTOMEGALOVIRUS IMMUNE GLOBULIN?
IMMUNOCYTOLOGY OF URINARY SEDIMENTS AS A METHOD OF DIFFERENTIATING ACUTE REJECTION FROM OTHER CAUSES OF DECLINING RENAL GRAFT FUNCTION
SEROLOGICAL RESPONSES TO CYTOMEGALOVIRUS DURING RENAL TRANSPLANT REJECTION
EVIDENCE THAT ADDITION OF AZATHIOPRINE IMPROVES RENAL FUNCTION IN CYCLOSPORINE-TREATED PATIENTS WITH ALLOGRAFT DYSFUNCTION
EFFECTS OF DILTIAZEM UPON METABOLISM AND IMMUNOSUPPRESSIVE ACTION OF CYCLOSPORINE IN KIDNEY GRAFT RECIPIENTS
CORRELATION OF IN VITRO CD4+ T HELPER CELL FUNCTION WITH CLINICAL GRAFT STATUS IN IMMUNOSUPPRESSED KIDNEY TRANSPLANT RECIPIENTS
EFFECT OF ANTI-LFA1 (CD11a) MONOCLONAL ANTIBODIES IN ACUTE REJECTION IN HUMAN KIDNEY TRANSPLANTATION
EXPRESSION OF THE INTERLEUKIN 2 RECEPTOR β CHAIN (p75) IN RENAL TRANSPLANTATION—APPLICABILITY OF ANTMNTERLEUKIN-2 RECEPTOR β CHAIN MONOCLONAL ANTIBODY
INTRAOPERATIVE ESTIMATION OF ENDOTOXIN, TNFα, AND IL-6 IN ORTHOTOPIC LIVER TRANSPLANTATION AND THEIR RELATION TO REJECTION AND POSTOPERATIVE INFECTION
DOES HISTOLOGIC ACUTE REJECTION IN LUNG ALLOGRAFTS PREDICT THE DEVELOPMENT OF BRONCHIOLITIS OBLITERANS?
CYCLOSPORINE-ASSOCIATED SEIZURES IN BONE MARROW TRANSPLANT RECIPIENTS GIVEN BUSULFAN AND CYCLOPHOSPHAMIDE PREPARATIVE THERAPY
HEPATITIS C VIRUS INFECTION IN PATIENTS UNDERGOING ALLOGENEIC BONE MARROW TRANSPLANTATION
DEMONSTRATION OF LOCAL IMMUNOSUPPRESSION WITH METHYLPREDNISOLONE IN THE SPONGE MATRIX
THE EFFECT OF A CHIMERIC MOUSE-HUMAN CD7 ANTIBODY ON HUMAN T, NATURAL KILLER, AND LYMPHOKINE-ACTIVATED KILLER CELL ACTIVITY IN VITRO
IMMUNE RESPONSES TO NONINHERITED MATERNAL RTIA ANTIGENS IN INBRED RATS
EFFECTS OF SMS 201–995 ON THE PHARMACOKINETIC PROFILE AND CELLULAR IMMUNE AND TOXIC EFFECTS OF CYCLOSPORINE IN MALE WISTAR RATS
THE IMMUNOCHEMICAL DISTRIBUTION OF CYCLOPHILIN IN NORMAL MAMMALIAN TISSUES
AGE-RELATED DIFFERENCES IN THE EFFECTS OF CYCLOSPORINE ON LYMPHOCYTE INTRACELLULAR FREE CALCIUM
PHOSPHOLIPASE-C AND NA-K ATPASE ACTIVATION BY CYCLOSPORINE AND FK506 IN LLC-PK1, CELLS
OKT3 F(AB')2 FRAGMENTS—RETENTION OF THE IMMUNOSUPPRESSIVE PROPERTIES OF WHOLE ANTIBODY WITH MARKED REDUCTION IN T CELL ACTIVATION AND LYMPHOKINE RELEASE
ANTI-CD3 MONOCLONAL ANTIBODY THERAPY
MAPPING AND TRANSCRIPTIONAL PROPERTIES OF RT1 CLASS II REGION GENES
HLA-DP INCOMPATIBILITIES AND SEVERE GRAFT-VERSUS-HOST DISEASE IN UNRELATED BONE MARROW TRANSPLANTS
LONG-TERM FOLLOW-UP OF THE FATE OF XENOGENEIC TRANSPLANTS OF CHONDROCYTES IMPLANTED INTO JOINT SURFACES
IN VITRO SUPPRESSION OF CYTOTOXIC T CELL GENERATION BY LYMPHOCYTES FROM MICE RENDERED NEONATALLY TOLERANT OF CLASS II MHC ALLOANTIGENS
STABILITY OF REDUCED GLUTATHIONE IN SOLUTIONS FOR ORGAN PRESERVATION STORED IN MULTILAYER BAGS VERSUS EVA BAGS
ERRATUM